[vc_row][vc_column width=”2\/3″][vc_column_text]<\/p>\n
1. Management of sight loss and other disease and treatment related complications<\/strong> [\/vc_column_text][\/vc_column][vc_column width=”1\/3″][vc_single_image image=”1211″ img_size=”full”][vc_single_image image=”1074″ img_size=”full”][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":" [vc_row][vc_column width=”2\/3″][vc_column_text] 1. Management of sight loss and other disease and treatment related complications Polymyalgia Rheumatica and Giant Cell Arteritis, Oxford University Press, March 2016 2. A pragmatic approach to imaging in large vessel vasculitis Expert Opinion on Orphan Drugs, June 2015 3. Fast track pathway reduces sight loss in giant cell arteritis: results of<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"translation":{"provider":"WPGlobus","version":"3.0.0","language":"mr","enabled_languages":["en","mr"],"languages":{"en":{"title":true,"content":true,"excerpt":false},"mr":{"title":true,"content":true,"excerpt":false}}},"yoast_head":"\n
\nPolymyalgia Rheumatica and Giant Cell Arteritis, Oxford University Press, March 2016
\n2. A pragmatic approach to imaging in large vessel vasculitis<\/strong>
\nExpert Opinion on Orphan Drugs, June 2015
\n3. Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study<\/strong>
\nClinical and experimental rheumatology, May 2015
\n4. Isolated Anti-Ro52 Antibody \u2013 Significance And Clinical Association<\/strong>
\nArthritis and Rheumatology, Oct 2013
\n5. Methotrexate-induced nausea and vomiting in adolescent and young adult patients<\/strong>
\nClinical Rheumatology, Oct 2013
\n6. Polymyalgia rheumatica in older adults<\/strong>
\nAging Health, Oct 2013
\n7. How not to miss PMR<\/strong>
\nPulse magazine for general practitioners, Aug 2013
\n8. Giant cell arteritis: a review<\/strong>
\nEye and Brain, Mar 2013
\n9. Successful use of tocilizumab in the treatment of refractory fdg pet-positive large vessel vasculitis: A case series<\/strong>
\nRheumatology (Oxford, England), Apr 2013
\n10. Treatment of polymyalgia rheumatica<\/strong>
\nExpert Opinion on Orphan Drugs, Feb 2013
\n11. Imaging indications in polymyalgia rheumatica<\/strong>
\nInternational Journal of Clinical Rheumatology, Jan 2013
\n12. Role of diagnostic ultrasound in the assessment of musculoskeletal diseases<\/strong>
\nTherapeutic advances in musculoskeletal disease, Oct 2012
\n13. Contribution of imaging in Polymyalgia Rheumatica<\/strong>
\nJoint, bone and spine, Sep 2012
\n14. Undetectable Rheumatoid Factor Following Treatment with Rituximab- What Is Clinical Significance?<\/strong>
\nArthritis & Rheumatology, Sep 2011<\/p>\n